Phase II and Phase III attrition rates 2011–2012

Arrowsmith, John, Miller, Philip·2013·Nature Reviews Drug Discovery
DOI 10.1038/nrd4090

Cited by (697)

Items 301–400 of 697

  1. Preclinical species gene expression database: Development and meta-analysis
    Caitlin Krause, Kinga Suwada, Eric A.G. Blomme, Kenneth L. Kowalkowski, Michael J. Liguori, Prathap Kumar S. Mahalingaiah, Scott W. Mittelstadt, Richard Peterson, Lauren Rendino, Andy H. Vo et al. · 2023 · Frontiers in Genetics
  2. Deep learning assisted high throughput screening of ionic liquid electrolytes for NRR and CO2RR
    Yingying Song, Yandong Guo, Junwu Chen, Menglei Yuan, Kun Dong · 2023 · Journal of environmental chemical engineering
  3. Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward
    Alexander Alex, Dennis A. Smith, Cherell Harris · 2015
  4. Measurement and models accounting for cell death capture hidden variation in compound response
    Song Yi Bae, Ning Guan, Rui Yan, Katrina Warner, Scott D. Taylor, Aaron S. Meyer · 2020 · Cell Death and Disease
  5. Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations
    Kristin Calar, Simona Plesselova, Somshuvra Bhattacharya, Megan M. Jorgensen, Pilar de la Puente · 2020 · Cancers
  6. Evolution of precision oncology‐guided treatment paradigms
    Ramanuj DasGupta, Aixin Yap, Elena Yaqing Yong, Shumei Chia · 2022 · WIREs Mechanisms of Disease
  7. Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy
    Eugene J. Pietzak, James Andrew Eastham · 2016 · Current Urology Reports
  8. Testing regimes in clinical trials: Evidence from four polio vaccine trajectories
    Ohid Yaqub · 2016 · Research Policy
  9. Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma
    Kenneth R. Gundle, Gary B. Deutsch, Howard J. Goodman, Seth M. Pollack, Matthew J. Thompson, Jessica L. Davis, Mee-Young Lee, Daniel C. Ramirez, William S. Kerwin, Jessica A. Bertout et al. · 2020 · Clinical Cancer Research
  10. Complement-ARIE: Catalyzing the development and adoption of new approach methodologies
    Kristifor Sunderic, Andrew M. Wright, Nicole Kleinstreuer, Victoria Ledbetter, Katelynn A. Milora, Christine Happel, Daniel T. Shaughnessy, Chariz Peñalber‐Johnstone, Daniel Anthony Casco, Nikeya Macioce et al. · 2025 · NAM journal.
  11. Exposure-Effect Relationships in Established Rat Adjuvant-Induced and Collagen-Induced Arthritis: A Translational Pharmacokinetic-Pharmacodynamic Analysis
    Harvey Wong, Lichuan Liu, Wenjun Ouyang, Yuzhong Deng, Matthew R. Wright, Cornelis E. C. A. Hop · 2019 · Journal of Pharmacology and Experimental Therapeutics
  12. Strategic, feasibility, economic, and cultural aspects of phase 0 approaches
    Tal Burt, Ad F. Roffel, Oliver Langer, Kirsten Anderson, Joseph A. DiMasi · 2022 · Clinical and Translational Science
  13. Development of Organs-on-Chips and Their Impact on Precision Medicine and Advanced System Simulation
    Ying Luo, Xiaoxiao Li, Yawei Zhao, Wen Zhong, Malcolm M. Q. Xing, Guozhong Lyu · 2023 · Pharmaceutics
  14. Novel Insights in Drug Metabolism by MS Imaging
    Yutaka Sugihara, Kenichi Watanabe, Ákos Végvári · 2016 · Bioanalysis
  15. Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer
    Andrew Zloza, Karolina Palucka, Lisa M. Coussens, Philip J. Gotwals, Mark B. Headley, Elizabeth M. Jaffee, Amanda W. Lund, Arlene H. Sharpe, Mario Sznol, Derek Alan Wainwright et al. · 2017 · Journal for ImmunoTherapy of Cancer
  16. Neurofunctional test batteries in safety pharmacology – Current and emerging considerations for the drug development process
    Samuel J. Jackson, Simon Authier, Henning Brohmann, Susan M.G. Goody, David Jones, Helen M. Prior, Anke Rosch, Martin Traebert, Karen K.-Y. Tse, Jean Pierre Valentin et al. · 2019 · Journal of Pharmacological and Toxicological Methods
  17. Advanced Animal Replacement Testing Strategies Using Stem Cell and Organoids
    Chang-Jin Lee, Yoojun Nam, Yeri Alice Rim, Ji Hyeon Ju · 2025 · International Journal of Stem Cells
  18. Application of Organ-on-Chip in Drug Discovery
    Jiahui Zhu · 2020 · Journal of Biosciences and Medicines
  19. PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma
    Marlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, Astrid Monecke, Ines Gockel, Arved Weimann, Guido Schumacher, Ingo Bechmann, Florian Lordick, Sonja Kallendrusch et al. · 2021 · OncoImmunology
  20. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
    Satoko Namba, M Iwata, Yoshihiro Yamanishi · 2022 · Bioinformatics
  21. A Bayesian paradigm for decision-making in proof-of-concept trials
    Erik P. Pulkstenis, Kaushik Patra, Jianliang Zhang · 2017 · Journal of Biopharmaceutical Statistics
  22. Nanotechnology for pharmaceuticals
    Maryam Ghaffari, Ali Ezzati · 2019 · Elsevier eBooks
  23. Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
    Fen Yang, Baolian Wang, Zhihao Liu, Xuejun Xia, Weijun Wang, Dali Yin, Sheng Li, Yan Li · 2017 · Frontiers in Pharmacology
  24. In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development
    Karen Tilmant, Helga H.J. Gerets, Pierrette De Ron, Étienne Hanon, Claudia Bento‐Pereira, Franck Atienzar · 2018 · Toxicology in Vitro
  25. Focusing on Relevance: CETSA-Guided Medicinal Chemistry and Lead Generation
    Stina Lundgren · 2019 · ACS Medicinal Chemistry Letters
  26. Advanced Biomanufacturing Technologies for Micro-physiological Systems
    Min Kyeong Kim, Jungbin Yoon, Dohui Kim, Jae‐Seok Kim, Jae-Seok Kim, Gyugang Go, Junhyeok Song, Seunghun Son, Kyungdeok Park, Donghan Lee et al. · 2025 · International Journal of Precision Engineering and Manufacturing
  27. Overcoming the barriers of two-dimensional cell culture systems with three-dimensional cell culture systems: techniques, drug discovery, and biomedical applications
    Ankita Borah, D. Sakthi Kumar · 2022 · Elsevier eBooks
  28. Testing of putative antiseizure medications in a preclinical Dravet syndrome zebrafish model
    Paige Whyte‐Fagundes, Anjelica Vance, Aloe Carroll, Francisco Figueroa, Catherine Manukyan, Scott C. Baraban · 2024 · Brain Communications
  29. Dynamic 3D in vitro lung models: applications of inorganic nanoparticles for model development and characterization
    Laura Fallert, Ane Urigoitia-Asua, Amaia Cipitria, Dorleta Jiménez de Aberasturi · 2024 · Nanoscale
  30. Improving productivity of modern-day drug discovery
    Matthew Douglas Breyer · 2013 · Expert Opinion on Drug Discovery
  31. Neural layer self-assembly in geometrically confined rat and human 3D cultures
    Md Fayad Hasan, Shabnam Ghiasvand, Huaixing Wang, Julie M. Miwa, Yevgeny Berdichevsky · 2019 · Biofabrication
  32. Environmental epidemiology and risk assessment: Exploring a path to increased confidence in public health decision-making
    Sandrine E. Déglin, Connie L. Chen, David J. Miller, R. Jeffrey Lewis, Ellen T. Chang, Ali K. Hamade, Heidi S. Erickson · 2021 · Global Epidemiology
  33. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19
    Miriane de Oliveira, Maria Teresa De Síbio, Felipe Allan da Silva da Costa, Marna Eliana Sakalem · 2021 · ACS Biomaterials Science & Engineering
  34. New pharmacological effect of fulvestrant to prevent oxaliplatin‐induced neurodegeneration and mechanical allodynia in rats
    Shota Yamamoto, Tomohiro Yamashita, Mayu Ito · 2018 · International Journal of Cancer
  35. The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery
    Manuela Jörg, Katrina S. Madden · 2021 · RSC Medicinal Chemistry
  36. BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs
    Shuang Li, Liuchao Zhang, Liuying Wang · 2024 · Molecules
  37. Enhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope Tracers
    Natalie A. Daurio, Sheng-Ping Wang, Ying Chen, Haihong Zhou, David G. McLaren, Thomas P. Roddy, Douglas G. Johns, Denise P. Milot, Takhar Kasumov, Mark D. Erion et al. · 2017 · Journal of Pharmacology and Experimental Therapeutics
  38. Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use
    Frank R. Wendt, Dóra Koller, Gita A. Pathak, Daniel Louis Jacoby, Edward J. Miller, Renato A Polimanti · 2021 · Clinical Pharmacology & Therapeutics
  39. Tubulin is a molecular target of the Wnt-activating chemical probe
    Yasunori Fukuda, Osamu Sano, Ken‐ichi Kazetani, Koji Yamamoto, Hidehisa Iwata, Junji Matsui · 2016 · BMC Biochemistry
  40. 3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development
    Е. А. Соколова, Vladimir Vodeneev, Sergey Mikhailovich Deyev, Балалаева Ирина Владимировна · 2018 · Drug Discovery Today
  41. In Vitro Cell Models of the Human Blood-Brain Barrier: Demonstrating the Beneficial Influence of Shear Stress on Brain Microvascular Endothelial Cell Phenotype
    Keith D. Rochfort, Philip M. Cummins · 2018 · Neuromethods
  42. Small-Scale Panel Comprising Diverse Gene Family Targets To Evaluate Compound Promiscuity
    Tomoya Sameshima, Tomoya Yukawa, Yoshihiko Hirozane, Masato Yoshikawa, Taisuke Katoh, Hideto Hara, Takatoshi Yogo, Ikuo Miyahisa, Teruaki Okuda, Makoto Miyamoto et al. · 2019 · Chemical Research in Toxicology
  43. Predictive in vitro toxicology screening to guide chemical design in drug discovery
    Julia Johansson, Marie H. Larsson, Jorrit J. Hornberg · 2019 · Current Opinion in Toxicology
  44. Menagerie: A text-mining tool to support animal-human translation in neurodegeneration research
    Caroline J. Zeiss, Dongwook Shin, Brent Vander Wyk, Amanda P. Beck, Natalie Zatz, Charles A. Sneiderman, Halil Kilicoglu B · 2019 · PLoS ONE
  45. Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity
    Muhammad Erfan Uddin, Angie Moseley, Shuiying Hu, Alex Sparreboom · 2021 · Basic & Clinical Pharmacology & Toxicology
  46. The Current Landscape of Oral Squamous Cell Carcinoma: A Comprehensive Analysis from ClinicalTrials.gov
    Zhaolei Zou, Бин Ли, Shuqiong Wen, Dongjia Lin, Qian‐Nan Hu, Zhi Wang, Juan Fang · 2022 · Cancer Control
  47. 3D biofabricated in vitro models as new approach methodologies for animal alternatives
    Weijian Hua, Akhilesh K. Gaharwar · 2026 · npj Biomedical Innovations.
  48. Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans
    Minhyuk Park, Donghyo Kim, Inhae Kim, Sin‐Hyeog Im, Sanguk Kim · 2023 · EBioMedicine
  49. Establishment of a Tumour–Stroma Airway Model (OncoCilAir) to Accelerate the Development of Human Therapies against Lung Cancer
    Christophe Mas, Bernadett Boda, Mireille Caul-Futy, Song Huang, Ludovic Wisniewski, Samuel Constant · 2016 · Alternatives to Laboratory Animals
  50. A Comparative Study of Naive Bayes and k-NN Algorithm for Multi-class Drug Molecule Classification
    Lakshmi Mandal, Nanda Dulal Jana · 2019 · IEEE India Conference
  51. Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies
    Sören Sievers, Susanne Wieschowski, Daniel Strech · 2020 · British Journal of Clinical Pharmacology
  52. Quantitative structure–retention relationships of flavonoids unraveled by immobilized artificial membrane chromatography
    Adriana Leandra Santoro, Emanuel Carrilho, Fernando Mauro Lanças, Carlos Alberto Montanari · 2016 · European Journal of Pharmaceutical Sciences
  53. Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
    Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andréanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati et al. · 2023 · Oncology and Therapy
  54. Construct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models
    Rayanne Poletti Guimarães, Maria Clara Souza de Resende, Miguel Mesquita Tavares, Caio Vinícius Ibias Belardinelli de Azevedo, Miguel Cesar Merino Ruiz, Márcia Renata Mortari · 2024 · International Journal of Molecular Sciences
  55. Scaling Machine Learning for Target Prediction in Drug Discovery using Apache Spark
    Dries Harnie, Alexander E. Vapirev, Jörg K. Wegner · 2015 · IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing (CCGrid)
  56. Integrating High-Dimensional Transcriptomics and Image Analysis Tools into Early Safety Screening: Proof of Concept for a New Early Drug Development Strategy
    Bie M. P. Verbist, Geert R. Verheyen, Liesbet Vervoort, Marjolein Crabbe, Dominiek Beerens, Cindy Bosmans, Steffen Jaensch, Steven Osselaer, Willem Talloen, Ilse Van den Wyngaert et al. · 2015 · Chemical Research in Toxicology
  57. Innovative Technologies for Advancement of WHO Risk Group 4 Pathogens Research
    James Logue, Jeffrey M. Solomon, Brian F. Niemeyer, Kambez Hajipouran Benam, Aaron E. Lin, Zach B. Bjornson, Sizun Jiang, David R. McIlwain, Garry P. Nolan, Gustavo F. Palacios et al. · 2019 · Springer eBooks
  58. Next-Generation Human Liver Models for Antimalarial Drug Assays
    Kasem Kulkeaw · 2021 · Antibiotics
  59. Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured cells
    Jan A. Kaczmarczyk, Rhonda R. Roberts, Brian T. Luke, King C. Chan, Carly M. Van Wagoner, Robin Allen Felder, Richard G. Saul, Simona Colantonio, Josip Blonder · 2021 · Oncotarget
  60. Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
    Bao Jin, Yitong Liu, Shunda Du, Xinting Sang, Huayu Yang, Yilei Mao · 2022 · Frontiers in Cell and Developmental Biology
  61. Drug Targets, Target Identification, Validation, and Screening
    Walter M.M. Van den Broeck · 2015 · Elsevier eBooks
  62. Quantitative Systems Pharmacology: Applications and Adoption in Drug Development
    Saroja Ramanujan, Kapil G. Gadkar, Ananth Kadambi · 2016 · AAPS advances in the pharmaceutical sciences series
  63. Preformulation in Drug Research and Pharmaceutical Product Development
    Pratap Chandra Acharya, Saritha Rakesh Shetty, Clara Fernandes, Divya Suares, Rahul Maheshwari, Rakesh Kumar Tekade · 2018 · Elsevier eBooks
  64. Identification of Novel Analgesics Through a Drug Repurposing Strategy
    Parisa Gazerani · 2019 · Pain Management
  65. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases
    Kasem Kulkeaw, Worakamol Pengsart · 2021 · Micromachines
  66. The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system
    Maliheh Safavi, Reyhaneh Sabourian, Mohammad Reza Abdollahi · 2016 · Expert Opinion on Drug Discovery
  67. A Review of the Pharmaceutical R&D Efficiency: Costs, Timelines, and Probabilities
    Alexander Schuhmacher, Oliver Gassmann, Markus Hinder · 2016 · Wiley eBooks
  68. Advancement in Scaffold-Based 3D Cell Culture Models for Osteosarcoma Drug Screening
    Ponnamma Mandeda Madaiah, Rudra Nath Ghosh, Pramod Kesavan Namboothiri, Mathew Peter · 2025 · ACS Biomaterials Science & Engineering
  69. Humanized NSG Mouse Models as a Preclinical Tool for Translational Research in Inflammatory Bowel Diseases
    Veronika Weß, Paula Winkelmann, Yasemin Hazal Karatekin · 2023 · International Journal of Molecular Sciences
  70. Therapeutic target prediction for orphan diseases integrating genome-wide and transcriptome-wide association studies
    Satoko Namba, M Iwata, Shin‐ichi Nureki, Noriko Yuyama Otani, Yoshihiro Yamanishi · 2025 · Nature Communications
  71. Growing Preferences towards Analog-based Drug Discovery
    Mehak Dangi, Alka Khichi, Ritu Jakhar · 2020 · Current Pharmaceutical Biotechnology
  72. Improved Time Resolved KPI and Strain Characterization of Multiple Hosts in Shake Flasks Using Advanced Online Analytics and Data Science
    Rüdiger W. Maschke, Barbara Pretzner, Gernot Thomas John, Christoph Herwig, Dieter Eibl · 2022 · Bioengineering
  73. Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice
    Ryuji Watari, Motoharu Kakiki, Chihiro Yamasaki · 2019 · Biological and Pharmaceutical Bulletin
  74. Predicting clinically promising therapeutic hypotheses using tensor factorization
    Jin Jie Yao, Mark R. Hurle, Matthew R. Nelson, Pankaj Agarwal · 2019 · BMC Bioinformatics
  75. Anti-cancer potentials of aervine validated throughin silicomolecular docking, dynamics simulations, pharmacokinetic prediction andin vitroassessment of caspase – 3 in SW480 cell line
    Ramasamy Srinivasan, Desingu Kamalanathan, Thirumalaisamy Rathinavel, Muhammad Nasir Iqbal, Gnanendra Shanmugam · 2023 · Molecular Simulation
  76. Emerging applications of stimulated Raman scattering microscopy for medicinal chemistry and drug discovery
    Henry J. Braddick, William J. Tipping, Emma K. Grant, Nicholas C. O. Tomkinson, Karen Faulds, Duncan Graham · 2025 · Chemical Society Reviews
  77. GEMap: A comprehensive gene essentiality map for drug discovery
    Sai Tian, Yixue Liang, Jinbo Zhang, Weishan Liang, Jinyuan Lu, Jiajia Ren, Bojian Lin, Ruijun Wu, Chengyang Guo, Weidong Zhang · 2026 · Acta Pharmaceutica Sinica B
  78. A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
    Yi Zang, Jingjing Shi, Guanguan Zhao, Bixi Tang, Mingliang Liu, Benqiang Yao, Gaihong Wang, Hualing Pan, Shengsheng Yang, Rong Deng et al. · 2026 · Nature
  79. Global expansion of microphysiological systems (MPS) and Japan's initiatives: Innovation in pharmaceutical development and path to regulatory acceptance
    Daiju Yamazaki, Seiichi Ishida · 2024 · Drug Metabolism and Pharmacokinetics
  80. A Bright Future for Photopharmaceuticals Addressing Central Nervous System Disorders: State of the Art and Challenges Toward Clinical Translation
    Rudolf L. Z. Ganzoni, Sofie S. Bournons, Erick M. Carreira, Dimitri De Bundel, Ilse Julia Smolders · 2025 · Medicinal Research Reviews
  81. Monitoring additive manufacturing based products in clinical trials
    Yorgos Marinakis, Rainer Harms, Steven T. Walsh · 2017 · Translational Materials Research
  82. In vitro metabolism studies of natural products are crucial in the early development of medicines
    Fernanda de Lima Moreira, Lucas Maciel Mauriz Marques, Norberto Peporine Lopes, Anderson Rodrigo Moraes de Oliveira · 2016 · Phytochemistry Reviews
  83. Improving machine learning in early drug discovery
    Claus Bendtsen, Andrea Degasperi, Ernst Ahlberg, Lars Carlsson · 2017 · Annals of Mathematics and Artificial Intelligence
  84. Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity
    Feng Liu, Stephen J. Walters, Steven A. Julious · 2017 · BMC Medical Research Methodology
  85. Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
    Arzu Selen, Anette Müllertz, Filippos Kesisoglou, Rodney J. Y. Ho, Jack Cook, Paul Alfred Dickinson, Talia R. Flanagan · 2020 · The AAPS Journal
  86. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease
    Marie‐Pierre Dubé, Simon de Denus, Jean‐Claude Tardif · 2016 · Cardiovascular Drugs and Therapy
  87. Establishment of Animal Models of Drug-induced Liver Injury and Analysis of Possible Mechanisms
    Shingo Oda, Tsuyoshi Yokoi · 2015 · YAKUGAKU ZASSHI
  88. Kinetic Profile of Neuropeptide–Receptor Interactions
    Indira Nederpelt, Julia Bunnik, Adriaan P. IJzerman, Laura H. Heitman · 2016 · Trends in Neurosciences
  89. Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
    Hélène Lê, Jules Deforges, Pasquale Cutolo, Anissa Lamarque, Guoqiang Hua, Véronique Lindner, Shreyansh Jain, Jean‐Marc Balloul, Nadia Benkirane-Jessel, Éric Quéméneur · 2024 · Frontiers in Immunology
  90. Consideration of the Root Causes in Candidate Attrition During Oncology Drug Development
    Yin‐Ming Kuo, Jeffrey S. Barrett · 2024 · Clinical Pharmacology in Drug Development
  91. Innovations in skin microphysiological systems for nonclinical testing and FDA modernization
    Taeim Lee, Sang Yoon Kyung, Minseo Kwon, Byoungjun Park, Jihoon Ko · 2026 · Microsystems & Nanoengineering
  92. High-Throughput Dispensing of Viscous Solutions for Biomedical Applications
    Richard A. Revia, Brandon M. Wagner, Matthew James, Miqin Zhang · 2022 · Micromachines
  93. Message Passing Neural Networks Improve Prediction of Metabolite Authenticity
    Noah R. Flynn, S. Joshua Swamidass · 2023 · Journal of Chemical Information and Modeling
  94. Evaluating the Pharmacokinetics and Pharmacodynamics of Chemotherapeutics within a Spatial SILAC-Labeled Spheroid Model System
    Nicole C. Beller, Yijia Wang, Amanda B. Hummon · 2023 · Analytical Chemistry
  95. Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis
    Yuji Shirai, Shingo Oda, Sayaka Makino · 2017 · Laboratory Investigation
  96. Induced pluripotent stem cell-derived cardiomyocytes: A platform for testing for drug cardiotoxicity
    Daniel Bernstein · 2017 · Progress in Pediatric Cardiology
  97. Heart Rate Variability as a Translational Biomarker for Emotional and Cognitive Deficits
    Bart A. Ellenbroek, Meyrick Kidwell, Joyce Colussi‐Mas, Jiun Youn · 2019 · Handbook of behavioral neuroscience
  98. Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders
    Katerina Trajanoska, Fernando Rivadeneira · 2020 · Frontiers in Endocrinology
  99. Modular micro-physiological human tumor/tissue models based on decellularized tissue for improved preclinical testing
    Johanna Kühnemundt · 2020 · ALTEX
  100. TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response
    McMahon, Nathan P., Solanki, Allison, Wang, Lei G., Montaño, Antonio R., Jones, Jocelyn A., Samkoe, Kimberley S., Tichauer, Kenneth M., Gibbs, Summer L. · 2021 · Molecular Imaging and Biology